These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 31786845)
1. Effect of PD98059 on chemotherapy in patients with colorectal cancer through ERK1/2 pathway. Li Y; Yang Q J BUON; 2019; 24(5):1837-1844. PubMed ID: 31786845 [TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation. Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991 [TBL] [Abstract][Full Text] [Related]
3. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
4. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression. Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226 [TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase pathways may mediate the protective effect of electrical stimulation of the paraventricular nucleus against ischaemia-reperfusion injury of the gastric mucosa. Zhang YM; Wei EQ; Li L; Qiao WL; Wang L; Zhang JF Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):742-52. PubMed ID: 17600551 [TBL] [Abstract][Full Text] [Related]
6. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells. Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280 [TBL] [Abstract][Full Text] [Related]
7. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway. Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793 [TBL] [Abstract][Full Text] [Related]
8. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells. Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208 [TBL] [Abstract][Full Text] [Related]
10. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation. Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021 [TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway. Lu JT; Zhao WD; He W; Wei W Acta Pharmacol Sin; 2012 May; 33(5):691-700. PubMed ID: 22543708 [TBL] [Abstract][Full Text] [Related]
12. Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer. Xu R; Nakano K; Iwasaki H; Kumagai M; Wakabayashi R; Yamasaki A; Suzuki H; Mibu R; Onishi H; Katano M Cancer Lett; 2011 Jul; 306(2):151-60. PubMed ID: 21429662 [TBL] [Abstract][Full Text] [Related]
13. Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation. Cheng XD; Gu JF; Yuan JR; Feng L; Jia XB Mol Med Rep; 2015 Dec; 12(6):7992-8002. PubMed ID: 26498639 [TBL] [Abstract][Full Text] [Related]
14. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Yu C; Wang S; Dent P; Grant S Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609 [TBL] [Abstract][Full Text] [Related]
15. Leukaemia inhibitory factor mediated proliferation of HTR-8/SVneo trophoblast cells is dependent on activation of extracellular signal-regulated kinase 1/2. Prakash GJ; Suman P; Morales Prieto DM; Markert UR; Gupta SK Reprod Fertil Dev; 2011; 23(5):714-24. PubMed ID: 21635820 [TBL] [Abstract][Full Text] [Related]
16. Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. Di Paola R; Crisafulli C; Mazzon E; Genovese T; Paterniti I; Bramanti P; Cuzzocrea S Int J Immunopathol Pharmacol; 2009; 22(4):937-50. PubMed ID: 20074457 [TBL] [Abstract][Full Text] [Related]
17. [Effect of ERK1/2 Signaling Pathway Inhibitor PD98059 on the Expression of Ras, BRaf, MEK, ERK1/2 in Marrow Nucleated Red Blood Cells of CMS Patients]. Han YF; Ji LH; Feng TT; Liu F; Cui S; Su J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1571-1575. PubMed ID: 29070145 [TBL] [Abstract][Full Text] [Related]
18. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. Chang MC; Chen CA; Hsieh CY; Lee CN; Su YN; Hu YH; Cheng WF Biochem J; 2009 Dec; 424(3):449-58. PubMed ID: 19747165 [TBL] [Abstract][Full Text] [Related]
19. Sulforaphane inhibits invasion via activating ERK1/2 signaling in human glioblastoma U87MG and U373MG cells. Li C; Zhou Y; Peng X; Du L; Tian H; Yang G; Niu J; Wu W PLoS One; 2014; 9(2):e90520. PubMed ID: 24587385 [TBL] [Abstract][Full Text] [Related]
20. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. Yao J; Qian CJ; Ye B; Zhang X; Liang Y Life Sci; 2012 Sep; 91(5-6):186-93. PubMed ID: 22781708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]